Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$9.86 - $23.83 $23,328 - $56,381
-2,366 Reduced 1.26%
185,273 $1.87 Million
Q3 2022

Oct 18, 2022

BUY
$21.04 - $36.06 $191,169 - $327,641
9,086 Added 5.09%
187,639 $4.19 Million
Q2 2022

Aug 09, 2022

BUY
$17.78 - $42.39 $1.16 Million - $2.76 Million
65,173 Added 57.48%
178,553 $4.44 Million
Q1 2022

May 06, 2022

BUY
$29.67 - $60.28 $369,450 - $750,606
12,452 Added 12.34%
113,380 $4.4 Million
Q4 2021

Jan 26, 2022

BUY
$47.84 - $64.34 $349,566 - $470,132
7,307 Added 7.8%
100,928 $5.91 Million
Q3 2021

Nov 02, 2021

BUY
$59.27 - $95.73 $29,694 - $47,960
501 Added 0.54%
93,621 $5.55 Million
Q2 2021

Aug 05, 2021

BUY
$67.25 - $92.52 $248,556 - $341,953
3,696 Added 4.13%
93,120 $8.08 Million
Q1 2021

May 13, 2021

SELL
$72.16 - $117.4 $343,842 - $559,411
-4,765 Reduced 5.06%
89,424 $7.37 Million
Q4 2020

Feb 16, 2021

SELL
$38.09 - $100.95 $1.18 Million - $3.13 Million
-30,999 Reduced 24.76%
94,189 $8.57 Million
Q3 2020

Nov 06, 2020

BUY
$30.41 - $40.5 $226,889 - $302,170
7,461 Added 6.34%
125,188 $5 Million
Q2 2020

Aug 18, 2020

BUY
$20.21 - $35.23 $85,953 - $149,833
4,253 Added 3.75%
117,727 $4.04 Million
Q1 2020

May 08, 2020

BUY
$17.28 - $31.88 $567,181 - $1.05 Million
32,823 Added 40.7%
113,474 $2.52 Million
Q4 2019

Feb 07, 2020

BUY
$13.39 - $20.73 $1.08 Million - $1.67 Million
80,651 New
80,651 $1.58 Million

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $222M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Wcm Investment Management, LLC Portfolio

Follow Wcm Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wcm Investment Management, LLC with notifications on news.